Jazz Pharmaceuticals Denmark ApS
CVR 39791447 · Private limited company (ApS) · Active · Low risk
Jazz Pharmaceuticals Denmark ApS is a Private limited company (ApS), founded on , based in København V. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 7 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 13.8m and a net result of DKK 1.5m. CEO: Kamilla Enggaard Have, David James Spackman.
Bankruptcy risk for Jazz Pharmaceuticals Denmark ApS
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39791447
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Kampmannsgade 2
1604 København V - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 50k
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 4 of 7 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 30.7% |
| Current ratio | 144% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 5 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 38 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 41.0m | DKK 36.7m | DKK 31.7m |
| Net profit | DKK 1.5m | DKK 1.5m | DKK 595k |
| Equity | DKK 13.8m | DKK 12.3m | DKK 10.8m |
| Total assets | DKK 45.0m | DKK 32.5m | DKK 36.1m |
| Cash | DKK 8.4m | DKK 5.2m | – |
| Short-term debt | DKK 31.2m | DKK 20.2m | – |
| Tax owed | DKK 0 | DKK 41k | – |
| Avg. employees | 19 | 18 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · KPMG.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 191 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 182 | ||
| 1 Jan 2023 – 31 Dec 2023 | 183 | Restated | |
| 1 Jan 2022 – 31 Dec 2022 | 166 | ||
| 1 Jan 2021 – 31 Dec 2021 | 192 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 215 | Late | |
| 17 Aug 2018 – 31 Dec 2019 | 241 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Kamilla Enggaard Have | Current | |
| CEO | David James Spackman | Current | |
| CEO | Joseph Dagher | ||
| CEO | Samantha Jane Laura Pearce | ||
| Owner (100%) | Jazz Pharmaceuticals Ireland Holdings Limited | Current | |
| Owner (100%) | Jazz Pharmaceuticals Ireland Limited | ||
| Auditor | KPMG P/S | Current | |
| Founder | Jazz Pharmaceuticals Ireland Limited | Current |
The CEOs' other companies
Kamilla Enggaard Have – 1 other companies
- Hedia ApS Active
Address history (5 moves)
| Kampmannsgade 2, 1604 København V | |
| Gammel Kongevej 1, 1610 København V | |
| c/o Regus Management, Lautruphøj 1, 2750 Ballerup | |
| Gammel Kongevej 1, 1610 København V | |
| c/o Regus Management, Lautruphøj 1, 2750 Ballerup | |
| c/o Kromann Reumert, Sundkrogsgade 5, 2100 København Ø |
Other companies at the same address
- Cherry Tree Valley ApS Bankrupt
- Umwelt Energy ApS Bankrupt
- AKAMAI TECHNOLOGIES DENMARK ApS Active
- Avanti Gruppen ApS Active
- BP AVIATION A/S Active
- BP DANMARK A/S Opløst
- BS Denmark ApS Active
- COMPUSYSTEM ApS Active
- Castrol Denmark A/S Active
- Celltrion Healthcare Denmark ApS Active
- Cleandesk ApS Active
- Compliance Team ApS Active
- DEVOTEAM TECHNOLOGY CONSULTING A/S Active
- Devoteam A/S Active
- Devoteam Cloud Platforms A/S Active
- Devoteam Creative Tech ApS Fusioneret
- Devoteam Data Driven ApS Active
- Fokus Translatørerne A/S Active
- Future Works ApS Active
- JERA Nex bp Danmark ApS Active
- MATTEL NORTHERN EUROPE A/S Active
- Moodys Analytics Denmark ApS Active
- Reagle ApS Active
- Reuters News & Media Denmark ApS Active
- SEPHORA DANMARK ApS Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about Jazz Pharmaceuticals Denmark ApS
Has Jazz Pharmaceuticals Denmark ApS gone bankrupt?
No, Jazz Pharmaceuticals Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Jazz Pharmaceuticals Denmark ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of Jazz Pharmaceuticals Denmark ApS?
Kamilla Enggaard Have, David James Spackman are the CEOs of Jazz Pharmaceuticals Denmark ApS.
Who is the auditor of Jazz Pharmaceuticals Denmark ApS?
Jazz Pharmaceuticals Denmark ApS most recently used KPMG P/S.
When was Jazz Pharmaceuticals Denmark ApS founded?
Jazz Pharmaceuticals Denmark ApS was founded on 17 August 2018.
What is the equity of Jazz Pharmaceuticals Denmark ApS?
Equity was DKK 13.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.